Curay, the top FDA drug regulator, acknowledged that much is still in flux at the agency and introduced a new deputy.

Childhood vaccinations coverage slowed significantly even before the onset of the Covid-19 pandemic, a new study found.

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

The U.S. may be headed for a “choose your own adventure” approach to vaccine policy, in which skeptical parents follow the ...

We have had the ability to prevent nearly all cases of measles for more than 60 years. Yet the number of cases keeps growing.

She wrote that she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering ...

Cheatham is the new head of health care and life sciences at Breyer Capital, the investment office of Jim Breyer, who is ...

The decision by Health and Human Services Secretary Robert F. Kennedy Jr. to remove and replace all members of the government ...

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by ...

Regeneron is hoping a new program will widen patient access to its eye drug without also benefiting the company's rivals — a ...

In one of the most substantial deals of the year so far, Abridge on Tuesday announced it raised a $300 million Series E ...

New data indicate a targeted drug from Nuvalent could help patients with a rare lung cancer for whom other drugs stopped ...